Article in Journal of epidemiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Naomi MatsumotoDepartment of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University.ORCID 0000-0002-9980-6092
Tomoka KadowakiDepartment of Epidemiology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.ORCID 0000-0002-1546-5586
Rumi MatsuoDepartment of Epidemiology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.ORCID 0000-0001-9162-1395
Ayako SasakiDepartment of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University.
Chikara MiyajiDepartment of Epidemiology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.
Chigusa HiguchiOkayama University Health Service Center.
Masanori NakayamaOffice of Innovative Medicine, Organization for Research Strategy and Development, Okayama University.
Yasue SakuradaDepartment of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.
Hideharu HagiyaDepartment of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.
Soshi TakaoDepartment of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University.ORCID 0000-0002-7628-1254
Fumio OtsukaDepartment of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.
Takashi YorifujiDepartment of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University.ORCID 0000-0003-2543-5441
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Association Between Fever and Antibody Titer Trends After a Third Dose of the mRNA-1273 Vaccine. · full record | OpenQuestion